Literature DB >> 31145535

Hemocompatibility of different burn wound dressings.

Markus Denzinger1, Manuel Held1, Hanna Scheffler1,2, Hanna Haag3, Andreas K Nussler2, Hans Peter Wendel3, Christian Schlensak3, Adrien Daigeler1, Stefanie Krajewski3.   

Abstract

A variety of wound dressing are available for burns. Furthermore, although their impacts on wound healing have been studied sufficiently, their effects on blood remain unclear. Meanwhile, this aspect is extremely important, since blood interacts with the wound dressing, especially in extensive burn injuries. Therefore, the aim of this study is to evaluate the hemocompatibility and immunogenicity of different burn wound dressings. Accordingly, human whole blood (n = 5) was anticoagulated with heparin, treated with different wound dressings and incubated at 37°C for 30 minutes. Different parameters for coagulation and hemocompatibility were evaluated before and after incubation. Consequently, Jelonet, Xenoderm, and Matriderm showed higher TAT-III concentrations, Jelonet, Xenoderm, EZ Derm, and Matriderm were higher β-thromboglobulin; EZ Derm and Burntec showed higher SC5b-9 concentrations after incubation with whole blood. Our ex vivo study provided initial insights into the hemocompatibility and immunogenicity of different burn wound dressings. Moreover, Xenografts (Xenoderm and EZ Derm), Jelonet and Matriderm showed a hemostyptic effect, while EZ Derm and Burntec activated the complement system. Therefore, further studies must be conducted to analyze the possible effects in vivo.
© 2019 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31145535     DOI: 10.1111/wrr.12739

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  1 in total

1.  Evaluation of a Multifunctional Polyvinylpyrrolidone/Hyaluronic Acid-Based Bilayer Film Patch with Anti-Inflammatory Properties as an Enhancer of the Wound Healing Process.

Authors:  Marco Contardi; Maria Summa; Pasquale Picone; Ornella Roberta Brancato; Marta Di Carlo; Rosalia Bertorelli; Athanassia Athanassiou
Journal:  Pharmaceutics       Date:  2022-02-22       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.